Compare TECH & FDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TECH | FDS |
|---|---|---|
| Founded | 1976 | 1978 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2B | 10.0B |
| IPO Year | N/A | N/A |
| Metric | TECH | FDS |
|---|---|---|
| Price | $58.52 | $190.34 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 13 | 11 |
| Target Price | $72.67 | ★ $309.10 |
| AVG Volume (30 Days) | ★ 2.6M | 1.2M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | 0.55% | ★ 2.14% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2.49 | $6.56 |
| Revenue Next Year | $6.40 | $5.30 |
| P/E Ratio | $112.66 | ★ $12.09 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $46.01 | $185.00 |
| 52 Week High | $72.16 | $474.79 |
| Indicator | TECH | FDS |
|---|---|---|
| Relative Strength Index (RSI) | 35.31 | 23.15 |
| Support Level | $58.04 | $190.58 |
| Resistance Level | $69.92 | $206.22 |
| Average True Range (ATR) | 2.89 | 14.52 |
| MACD | -1.09 | -3.92 |
| Stochastic Oscillator | 4.34 | 6.22 |
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
FactSet provides financial data and portfolio analytics to the global investment community. The company aggregates data from third-party data suppliers, news sources, exchanges, brokerages, and contributors into its workstations. In addition, it provides essential portfolio analytics that companies use to monitor portfolios and address reporting requirements. Buy-side clients (including wealth and corporate clients) account for over 80% of FactSet's annual subscription value. In 2015, the company acquired Portware, a provider of trade execution software. In 2017, it acquired BISAM, a risk management and performance measurement provider. In 2022, it completed its purchase of CUSIP Global Services.